Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles Reduces Fasting Blood Glucose Levels without Compromising Insulinemia: A Preclinical Study

In vivo studies show the benefits of the trypsin inhibitor isolated from tamarind (Tamarindusindica L.) (TTI) seeds in satiety and obesity. In the present study, TTI nanoencapsulation (ECW) was performed to potentialize the effect of TTI and allow a controlled release in the stomach. The impact on g...

Descripción completa

Detalles Bibliográficos
Autores principales: Matias, Lídia L. R., Costa, Rafael O. A., Passos, Thaís S., Queiroz, Jaluza L. C., Serquiz, Alexandre C., Maciel, Bruna L. L., Santos, Pedro P. A., Camillo, Christina S., Gonçalves, Catarina, Amado, Isabel R., Pastrana, Lorenzo, Morais, Ana H. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893787/
https://www.ncbi.nlm.nih.gov/pubmed/31739532
http://dx.doi.org/10.3390/nu11112770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893787/
https://www.ncbi.nlm.nih.gov/pubmed/31739532
http://dx.doi.org/10.3390/nu11112770

Ejemplares similares